Endorsers

Each year, The Lymphoma, Leukemia & Myeloma Congress teams up with various organizations, most focused on raising awareness, gaining funding for research, and providing patient support for different hematologic malignancies. Many of these endorsers will be on site during the meeting.

 

The Lymphoma Research Foundation (LRF) is the nation’s largest lymphoma-focused health organization devoted to improving care through education and support services and improving outcomes through investment in the most promising lymphoma research. LRF’s mission is to eradicate lymphoma and serve all those affected by this blood cancer. For more information: lymphoma.org. 
 

Clinical Lymphoma, Myeloma & Leukemia is the official peer-reviewed, monthly journal of the International Myeloma Society and the Society of Hematologic Oncology. 
 

The CLL Society is a patient-driven, physician-curated CLL education, support, and research nonprofit 501(c)(3) organization. Dedicated to the unmet needs of CLL (chronic lymphocytic leukemia) and related cancer communities, it focuses on explaining the advances in our understanding of the underlying biology and the rapidly changing therapy options while supporting informed patients and their healthcare providers, researching the CLL journey, and supporting basic research. Our goal is to develop real, recent, and relevant education for patients and caregivers and to improve CLL care for all. Our motto is SMART PATIENTS GET SMART CARE™.

The mission of the IWMF is to offer mutual support and encouragement to the Waldenstrom’s macroglobulinemia (WM) community and others with an interest in the disease, to provide information and educational programs that address patients’ concerns, and to promote and support research leading to better treatments and, ultimately, a cure. The IWMF website iwmf.com is a valuable resource for publications, quarterly newsletter, and network of WM support groups and patient organizations in the US and abroad. IWMF holds a patient-educational forum in different areas of the US every year.  

 

The Aplastic Anemia and MDS International Foundation (AAMDSIF) is the world's leading nonprofit health organization dedicated to supporting patients and their families who are living with aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH), and related bone marrow failure diseases. Founded in 1983, AAMDSIF provides patient education resources, professional education programs, research grants, and advocacy for bone marrow failure disease research funding.
 

Ranked a top-5 hospital in the nation by U.S. News and World Report, NewYork-Presbyterian Hospital and Weill Cornell Medicine’s oncologists and hematologists provide comprehensive, patient-centered care for people with all forms of cancer and blood disorders. We incorporate the most advanced precision-medicine technologies to craft individualized treatment plans for every patient in order to maximize outcomes and quality of life while minimizing potential side effects. With a robust portfolio of over 1,000 clinical trials, the science of tomorrow is treatment that can be accessed at NewYork-Presbyterian Hospital and Weill Cornell Medicine today.
 

The Leukemia & Lymphoma Society (LLS) is a global leader in the fight to end cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease, and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care. Founded in 1949 and headquartered in Rye Brook, New York, LLS has chapters throughout the United States and Canada. To learn more, visit LLS.org.